|
TAF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58829999996613E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40059999997888E-06 |
| Normal-vs-Stage2 |
3.987900E-04 |
| Normal-vs-Stage3 |
2.094200E-01 |
| Normal-vs-Stage4 |
3.822200E-04 |
| Stage1-vs-Stage2 |
8.575800E-01 |
| Stage1-vs-Stage3 |
1.138400E-01 |
| Stage1-vs-Stage4 |
6.244000E-01 |
| Stage2-vs-Stage3 |
1.398810E-01 |
| Stage2-vs-Stage4 |
7.137000E-01 |
| Stage3-vs-Stage4 |
7.669800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.9088999999376E-07 |
| Normal-vs-AfricanAmerican |
7.86799999999976E-05 |
| Normal-vs-Asian |
4.939200E-01 |
| Caucasian-vs-AfricanAmerican |
8.535800E-01 |
| Caucasian-vs-Asian |
3.911600E-01 |
| AfricanAmerican-vs-Asian |
4.507400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32020000043198E-07 |
| Normal-vs-Female |
1.732150E-02 |
| Male-vs-Female |
6.519600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.012300E-04 |
| Normal-vs-Extreme_Weight |
4.26670000441831E-08 |
| Normal-vs-Obese |
7.191200E-04 |
| Normal-vs-Extreme_Obese |
2.470000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.583600E-01 |
| Normal_Weight-vs-Obese |
5.106800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.665600E-01 |
| Extreme_Weight-vs-Obese |
2.992500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.856200E-02 |
| Obese-vs-Extreme_Obese |
5.136600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.067700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.404500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.81959999956405E-07 |
| Normal-vs-Age(81-100Yrs) |
4.604700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.003600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.472400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.014200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.759840E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.057600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.248000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.71520000044912E-07 |
| Normal-VS-Type2 PRCC |
1.002010E-03 |
| Normal-VS-KIRP CIMP |
5.040500E-03 |
| Normal-VS-Unclassified PRCC |
8.311700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.831250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.789600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.883700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.063600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.926400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.968800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38219999999512E-05 |
| Normal-vs-N1 |
3.707600E-01 |
| Normal-vs-N2 |
1.095030E-03 |
| N0-vs-N1 |
5.009800E-02 |
| N0-vs-N2 |
3.570400E-01 |
| N1-vs-N2 |
1.541360E-01 |
|
|
